TSLA's fundamentals are deteriorating, with double-digit EPS declines, flat revenue growth, and declining gross margins. Read ...

CEO John Gibson announced that Paychex delivered total revenue growth of 5% in Q3 2025, with adjusted diluted EPS growing 8%. He noted that the acquisition of Paycor is expected to strengthen the ...

In the upside scenario, Jefferies gave a target price of ₹430 apiece, which is a 79 per cent upside for the stock ...

Darden Restaurants reported a 6.2% YoY revenue increase to $3.158 billion for Q3, falling short of consensus. The company's same-restaurant sales rose 0.7%, driven by acquisitions. Darden's operating ...

Biogen's Q4 adjusted EPS rose 17% to $3.44 ... including real-time stock ratings, insider trades, and government trading signals. The company reported sales of $2.46 billion, up 2% year over ...

ProMIS Neurosciences as we reached a major milestone with the initiation of our 100-patient Phase 1b clinical trial for PMN310, our lead an ...

the stock really lost its luster with shares sinking to multi-year lows last week. Against these downbeat expectations and mounting growth concerns due to the soft consumer spending environment, the ...